Post-operative Analgesia in Elective, Soft-tissue Hand Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02029235 |
|
Recruitment Status :
Terminated
(Early termination due to slower than anticipated recruitment.)
First Posted : January 7, 2014
Results First Posted : December 13, 2018
Last Update Posted : December 13, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Carpal Tunnel Ganglion Cyst Trigger Finger De Quervain Disease | Drug: Acetaminophen/Ibuprofen Drug: Acetaminophen/Hydrocodone | Phase 4 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 72 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Investigator) |
| Primary Purpose: | Treatment |
| Official Title: | Post-operative Analgesia in Elective, Soft-tissue Hand Surgery: A Randomized, Double Blind Comparison of Acetaminophen/Ibuprofen Versus Acetaminophen/Hydrocodone |
| Actual Study Start Date : | February 10, 2015 |
| Actual Primary Completion Date : | November 17, 2017 |
| Actual Study Completion Date : | June 30, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Acetaminophen/Ibuprofen (AIBU) Group
Acetaminophen 500 mg and Ibuprofen 400 mg
|
Drug: Acetaminophen/Ibuprofen
Postoperatively, subjects will be given acetaminophen 500 mg / ibuprofen 400mg every 4 hours, as needed, for one week or until essentially pain-free
Other Names:
|
|
Active Comparator: Acetaminophen/Hydrocodone (AH) Group
Acetaminophen 325 mg and Hydrocodone 5 mg
|
Drug: Acetaminophen/Hydrocodone
Postoperatively, subjects will be given acetaminophen 325 mg / hydrocodone 5 mg every 4 hours, as needed, for one week or until essentially pain-free
Other Name: Norco |
- Efficacy Comparison of Pain Intensity Level [ Time Frame: 1 week post-operatively ]
Subjects asked to fill out a patient diary recording their pain intensity level (on 100mm Visual Analog Scale) prior to taking study medication every 4 hours.
The daily average pain intensity levels are reported as a score on a scale of 0-100, with higher score meaning worse outcome.
The daily average pain levels were assessed daily for 1 week post-operatively, then compared between the 2 groups using a two-group Student's t-test.
- Efficacy Comparison of Pain Relief [ Time Frame: 1 week postoperatively ]
Subjects asked to fill out a patient diary recording their pain relief (on a Likert scale) one hour after taking study medication every 4 hours.
Daily average pain relief scores are reported as a score on a scale of 0-3, with higher score meaning better outcome.
The daily average pain relief scores were assessed daily for 1 week post-operatively, then compared using generalized linear mixed-effects models
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age greater than or equal to 18
- Male or Female (non-pregnant)
- Elective, soft tissue hand surgery indicated based on diagnosis made by either clinical exam or diagnostic studies (ie nerve conduction study, EMG) or a combination of the two (carpal tunnel release, trigger finger release, first dorsal compartment release, ganglion cyst excision, second extensor compartment release)
- Subjects are capable of giving informed consent
Exclusion Criteria:
- Allergy to study medication
- Any pre-existing pain condition requiring analgesia
- Fibromyalgia
- Recent upper gastrointestinal bleeding
- Coagulopathy (primary or medication-related)
- Renal impairment
- Liver disease
- Pregnancy
- Patients who consent to the study but require unexpected admission, including those requiring admission resulting from operative complications, will be excluded before randomization
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02029235
| United States, Pennsylvania | |
| Penn State Milton S. Hershey Medical Center | |
| Hershey, Pennsylvania, United States, 17033 | |
| Principal Investigator: | Alexander Payatakes, M.D. | Milton S. Hershey Medical Center |
Documents provided by Alexander Payatakes, M.D., Milton S. Hershey Medical Center:
| Responsible Party: | Alexander Payatakes, M.D., Principal Investigator / Sponsor, Milton S. Hershey Medical Center |
| ClinicalTrials.gov Identifier: | NCT02029235 |
| Other Study ID Numbers: |
IRB - 00076 |
| First Posted: | January 7, 2014 Key Record Dates |
| Results First Posted: | December 13, 2018 |
| Last Update Posted: | December 13, 2018 |
| Last Verified: | December 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Adult soft-tissue hand surgery |
|
Ganglion Cysts Trigger Finger Disorder De Quervain Disease Cysts Neoplasms Mucinoses Connective Tissue Diseases Tendon Entrapment Tendinopathy Muscular Diseases Musculoskeletal Diseases Acetaminophen Ibuprofen Acetaminophen, hydrocodone drug combination Hydrocodone |
Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Antipyretics Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Analgesics, Opioid Narcotics Central Nervous System Depressants |

